The Recall Desk
SevereFDA (Drugs)·D-0708-2020·Announced 2020-01-22

Assurance Infusion Recalls Buprenorphine and Fentanyl Injection Due to Sterility Concerns

Assurance Infusion is recalling specific lots of Buprenorphine and Fentanyl injection due to a lack of sterility assurance.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of infection associated with a lack of sterility assurance in an injectable drug.

Plain-English summary

Assurance Infusion is recalling specific lots of BUP 40MG/FENT 3000MCG/ML INJ in 20 mL syringe. The recall is being conducted because of a lack of sterility assurance for the product.

The affected product is distributed nationwide within the United States. The specific lot number is 12102019@5 with an expiration date of 12/19/2019.

Consumers and healthcare providers should stop using the affected product and contact Assurance Infusion at (713) 533-8800 for further instructions.

The recalled product

Product
BUP 40MG/FENT 3000MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
Manufacturer
Assurance Infusion
Category
Drug — Injectable
Hazard
Affected units
1

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lots: 12102019@5 Exp. 12/19/2019

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 118 recalled by Assurance Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 118 products in this recall →

Related recalls

Same manufacturer · Assurance Infusion

See all →

Same hazard · infection

See all →